NEOGENOMICS, INC. |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 28/05 | NeoGenomics, Inc. to Introduce Comprehensive Lung Solution & Feature Hematopathology Services At ASCO | CI |
| 02/05 | North American Morning Briefing : Stock Futures -3- | DJ |
Chart calendar NeoGenomics, Inc.
9477abbaf5379f03e965db24b.OOF_kMeSx-0wA-kXdnpd2fmIc0qW35RUQZdYtTP-y3M.DbIR873QpI5nVKojNA8ysr-5Rmf0maIBDtUvxnqPmx1nmyX5rd-tg2lGjg~d85b358c276f5eefd0e324ee86c24f1a
Upcoming events on NeoGenomics, Inc.
Past events on NeoGenomics, Inc.
| 23/05/2024 07:30 pm | Annual General Meeting |
| 30/04/2024 06:00 pm | Q1 2024 Earnings Call |
| 30/04/2024 05:00 pm | Q1 2024 Earnings Release |
| 10/04/2024 09:30 pm | American Association for Cancer Research Meeting - Poster No:20 |
| 10/04/2024 02:00 am | American Association for Cancer Research Meeting - Poster No:10 |
| 10/04/2024 02:00 am | American Association for Cancer Research Meeting - Poster No:30 |
| 10/04/2024 02:00 am | American Association for Cancer Research Meeting - Poster No:16 |
| 10/04/2024 02:00 am | American Association for Cancer Research Meeting - Poster No:5 |
| 09/04/2024 09:30 pm | American Association for Cancer Research Meeting - Poster No:8 |
| 09/04/2024 09:30 pm | American Association for Cancer Research Meeting - Poster No:35 |
| 08/04/2024 09:30 pm | American Association for Cancer Research Meeting - Poster No:26 |
| 08/04/2024 09:30 pm | American Association for Cancer Research Meeting - Poster No:30 |
| 08/04/2024 02:00 am | American Association for Cancer Research Meeting - Poster No:30 |
| 08/04/2024 02:00 am | American Association for Cancer Research Meeting - Poster No:17 |
| 05/03/2024 07:40 pm | TD Cowen Health Care Conference |
| 21/02/2024 03:00 am | Q4 2023 Earnings Call |
| 21/02/2024 02:35 am | Q4 2023 Earnings Release |
| 09/01/2024 06:45 am | JPMorgan Healthcare Conference |
| 29/11/2023 07:30 pm | Piper Sandler Healthcare Conference |
| 07/11/2023 03:00 am | Q3 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 409 406 0.66% | 444 443 0.44% | 484 485 -0.06% | 510 501 1.72% | 592 589 0.47% | 656 |
|
EBITDA Million USD | Released Forecast Spread | 57,2 57,5 -0.45% | 34,8 33,1 5.34% | -4,16 -2,03 -104.55% | -48,0 -59,2 18.87% | 3,49 -2,22 256.78% | 23,3 |
|
EBIT Million USD | Released Forecast Spread | 13,0 14,8 -12.1% | -14,0 -11,3 -24.31% | -119 -101 -17.11% | -158 -163 3.4% | -108 -105 -2.56% | -87,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3,65 3,82 -4.51% | -14,1 -18,3 23.21% | -15,1 -3,98 -278.65% | -159 -172 7.52% | -97,1 -104 6.51% | -78,8 |
|
Net income Million USD | Released Forecast Spread | 8,01 3,52 127.49% | 4,17 -8,48 149.22% | -8,35 0,68 -1325.95% | -144 -158 8.6% | -88,0 -93,9 6.31% | -72,1 |
|
EPS USD | Released Forecast Spread | 0,08 0,04 122.22% | 0,04 -0,08 150.79% | -0,07 0,00 -4091.62% | -1,16 -1,27 8.66% | -0,70 -0,75 6.04% | -0,57 |
| Announcement Date | 27/02/20 | 24/02/21 | 23/02/22 | 23/02/23 | 20/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 117 116 0.62% | 125 123 1.47% | 129 122 5.96% | 139 130 6.72% | 137 126 8.58% | 147 137 6.91% | 152 142 7.01% | 156 153 1.98% | 156 150 4.37% | 162 | 166 | 171 | 171 | 178 |
|
EBITDA Million USD | Released Forecast Spread | -19,0 -20,0 4.76% | -16,3 -18,8 13.37% | -11,6 -18,9 38.98% | -1,17 -11,7 90.06% | -7,12 -12,5 42.85% | -2,05 -8,34 75.4% | 3,31 -3,14 205.27% | 9,35 3,43 172.21% | 3,49 -0,57 713.51% | 3,68 | 5,88 | 10,3 | 6,57 | 11,9 |
|
EBIT Million USD | Released Forecast Spread | -52,0 -40,8 -27.49% | -39,7 -41,5 4.23% | -39,5 -40,3 1.89% | -26,4 -36,7 28.18% | -35,1 -36,1 2.87% | -29,9 -31,5 5.06% | -24,2 -27,7 12.63% | -18,6 -21,3 12.79% | -30,6 -27,7 -10.29% | -22,4 | -20,3 | -15,9 | -20,7 | -15,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -53,2 -43,2 -23% | -41,0 -45,1 8.99% | -39,6 -44,2 10.29% | -25,5 -38,5 33.65% | -33,7 -39,3 14.27% | -26,6 -33,0 19.27% | -21,5 -29,3 26.8% | -15,3 -21,8 29.93% | -27,7 -25,2 -9.79% | -19,9 | -18,4 | -13,7 | -17,7 | -13,1 |
|
Net income Million USD | Released Forecast Spread | -49,4 -42,8 -15.33% | -35,3 -42,1 16.08% | -36,9 -41,8 11.77% | -22,7 -36,3 37.42% | -30,8 -35,9 14.28% | -24,3 -30,0 18.98% | -18,5 -26,7 30.76% | -14,3 -20,0 28.24% | -27,1 -23,1 -17.06% | -17,6 | -16,1 | -11,8 | -15,8 | -11,6 |
|
EPS USD | Released Forecast Spread | -0,40 -0,35 -15.94% | -0,28 -0,34 16.95% | -0,30 -0,33 9.43% | -0,18 -0,29 38.2% | -0,25 -0,29 12.28% | -0,19 -0,24 20% | -0,15 -0,21 29.05% | -0,11 -0,16 30.16% | -0,21 -0,18 -15.75% | -0,14 | -0,13 | -0,09 | -0,12 | -0,09 |
| Announcement Date | 27/04/22 | 09/08/22 | 08/11/22 | 23/02/23 | 08/05/23 | 08/08/23 | 06/11/23 | 20/02/24 | 30/04/24 | - | - | - | - | - |
More events
Past sector events for NeoGenomics, Inc.
| 25/06/2024 04:42 am | HEALIUS LIMITED: Q4 2024 Sales and Revenue Release - Trading Update |
| 21/05/2024 05:52 pm | METROPOLIS HEALTHCARE LIMITED: Q4 2024 Earnings Release |
| 10/05/2024 01:40 pm | DR. LAL PATHLABS LIMITED: Q4 2024 Earnings Release |
| 10/05/2024 | H.U. GROUP HOLDINGS, INC.: Q4 2023 Earnings Release |
| 10/05/2024 | BML, INC.: Q4 2023 Earnings Release |
| 09/05/2024 | FLEURY S.A.: Q1 2024 Earnings Release |
| 09/05/2024 01:35 am | RADNET, INC.: Q1 2024 Earnings Release |
| 08/05/2024 04:09 pm | VIJAYA DIAGNOSTIC CENTRE LIMITED: Q4 2024 Earnings Release |
| 08/05/2024 10:30 am | SYNLAB AG: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | OPKO HEALTH, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- NEO Stock
- Stock
- Calendar NeoGenomics, Inc.
